Dr. Guy Ben Betzalel, MD

Director at Sheba Medical Center's Melanoma and Skin Cancer Clinic

Dr. Guy Ben Betzalel leads the Tumor-Infiltrating Lymphocytes (TIL) Program, which focuses on the treatment of melanoma., Sheba Medical Center

Educational Background and Career Development:
Dr. Ben Betzalel earned his medical degree from Debrecen University in Hungary. He completed a residency in medical oncology at Sheba Medical Center in Israel, where he has specialized in the study and treatment of melanoma.

Languages: Hebrew, English

Current Leadership Roles

• Director, Melanoma and Skin Cancer Clinic, Sheba Medical Center: Dr. Ben Betzalel directs this clinic, overseeing patient care and the application of research in clinical settings.
• Head, Melanoma Long-Term Follow-Up Clinic, Ella Institute for Immuno-Oncology, Sheba Medical Center: He manages follow-up care for melanoma patients, with a focus on long-term health outcomes.

Publications in Pubmed:

Professional Memberships

Dr. Ben Betzalel is a member of several oncology and cancer research organizations, which support his ongoing professional development and collaboration with other experts:

• Israeli Society for Clinical Oncology and Radiotherapy
• American Society of Clinical Oncology
• Israeli Society for Immuno-Oncology
• Israeli Society for Melanoma and Skin Cancer

In his leadership of the TIL Program, Dr. Ben Betzalel oversees the development and implementation of innovative melanoma treatments at Sheba Medical Center, contributing to the center’s efforts in cancer treatment research and therapy.

Dr. Guy Ben-Betzalel, head of Sheba TIL melanoma program with Tanya from Israeli Hospitals.

Links

1. CAR T-CELL THERAPY IN SHEBA
2. OVERVIEW OF THE CAR-T CELL THERAPY IN SHEBA:July 2023
3. WHAT IS THE DIFFERENCE BETWEEN SHEBA’S IN-HOUSE CAR-T THERAPY AND OTHER COMMERCIAL CAR-T’S?
4. WHY IS THE CAR-T CELL THERAPY AT SHEBA MEDICAL CENTER SUPERIOR TO OTHERS?
5. UNDERSTANDING THE COSTS OF CAR-T THERAPY AT SHEBA HOSPITAL